Regeneron, following in Lilly’s footsteps, wins FDA emergency nod for COVID-19 antibody cocktail
by Angus Liu | Nov 23, 2020 5:06am Regeneron has won FDA emergency use authorization for its COVID-19 antibody cocktail, casirivimab and imdevimab,
Read More